02.06.25 -- An Outsourcing Vibe At JP Morgan 25

With a combined 20-year track record in the manufacturing of lipids, LNP, and mRNA, MilliporeSigma offers customizable mRNA-LNP CDMO services to meet your unique needs from pre-clinical to commercialization. Select integrated services from drug substance to Fill & Finish or individual components tailored to your project. Download the infographic to learn more!

Let's demystify the design of experiments approach with simple tools for implementing two-level factorial experiments, including workbooks free to download.

Utilize these strategies to develop a functional equivalence model for single-use manufacturing equipment and assemblies for use in drug product manufacturing.

COVID-19 reshaped the pharmaceutical landscape, and its impact on the supply chain is undeniable. As the industry adapts to a new reality, executives are prioritizing reliable, forward-thinking partnerships.

Digital Twins are revolutionizing biotechnology by optimizing production processes, enhancing quality control, and changing the workforce. They offer a variety of benefits.

New higher volume, higher viscosity pharmaceutical formulations for subcutaneous injection, alternatives to traditional intravenous treatment, enable chronic disease therapy in alternate settings.

Review the process of planning and implementing a new fill line, focusing on identifying and mitigating contamination risks effectively.

Here, we review several challenges in biologics analysis and take a closer look at the advanced tools and methods being utilized to improve biophysical analysis reliability and efficiency.

Examine a platform process that is emerging as a simplified and reliable solution for ADC manufacturing, offering efficient process development, purification techniques, and optimization strategies.

Explore how our contract manufacturing solutions can help you meet the growing demand for seasonal influenza vaccines efficiently and effectively.

Consider the benefits of the XS Pichia 2.0, including speed, simple fermentation regimes, and robust, scalable processes that can be tuned according to a program's specific objectives.

In cell line development, application of targeted integration cell line technology boosts development speed. Then, a proven production platform facilitates seamless scaleup to GMP manufacturing.

Pionyr Immunotherapeutics, a biotech with a pipeline of first-in-class clinical-stage cancer immunotherapies, needed a CDMO to help rapidly develop a third lead candidate from the start.

Access a comprehensive suite of biologics testing services meeting cGMP standards, covering characterization, biosafety, and quality control release testing.

We are an established leader in advancing vaccines from preclinical development to commercial supply across multiple modalities.

Partner with a global network of cGMP-certified mammalian cell culture manufacturing facilities to ensure scalable, high-quality biologics production and seamless global supply.

Scaling your drug product from concept to commercial supply requires having the expertise to ask the right questions about your end goals, from the start.